These include (2R, 3R, 4R, 5R) - 5 - (4-amino-2-oxo-2H-pirimidin-1-il) - 4-fluoro-2-isobutirioximethy-4-meth-tetrahydro-furan-3-il ester de acido isobutirico and hydroxyl-cellulose; and for the treatment of hepatitis C virus-mediated diseases.

摘要

Pharmaceutical composition comprising a prodrug of the polymerase inhibitor of hepatitis C virus; and use in the treatment of a disease mediated by hepatitis C virus